Lactobacillus crispatus and Reduced Type 2 Immune Responses

• Lactobacillus crispatus KBL693 alleviates atopic dermatitis symptoms through immune modulation.

  • 2025-10-31
  • Journal of microbiology (Seoul, Korea) 63(10)
  • • Seokcheon Song
    • Jun-Hyeong Kim
    • Sung Jae Jang
    • Eun Jung Jo
    • Sang Kyun Lim
    • GwangPyo Ko

  • PubMed: 41164963
  • DOI: 10.71150/jm.2509005

  3 Insights on

  • Reduced Type 2 Immune Responses

  • Low evidence

  KBL693 suppressed mast cell degranulation and IL-4 production by T cells, suggesting its ability to attenuate key type 2 immune responses

  Effect

  Beneficial

  Effect size

  Moderate